Compagnie de Saint-Gobain Disposal

RNS Number : 3449F

Compagnie de Saint-Gobain

01 March 2024

 

 

SAINT-GOBAIN DIVESTS ITS
TREATED TIMBER BUSINESSES IN THE UK & IRELAND

 

Saint-Gobain has signed a binding agreement for the sale of its treated timber products (utility poles, fencing and railway sleepers) manufacturing brands: PDM in Ireland and Calders & Grandidge in the UK - to the Iivari Mononen Group.

 

The divested assets, comprising two business units in Ireland and the UK, generated revenues of €50 million in 2023 and employ 80 people.

 

The divestment of PDM completed today, and the sale of Calders & Grandidge is expected to be completed by the end of 2024, subject to competition authority clearance.

 

These divestments are part of Saint-Gobain's continued business profile optimization strategy, in line with its "Grow & Impact" plan.

 

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose, "MAKING THE WORLD A BETTER HOME".

 

€47.9 billion in sales in 2023

160,000 employees, locations in 76 countries

Committed to achieving Carbon Neutrality by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

 

 

Analyst/investor relations		Press relations
Vivien Dardel:	[phone]	Patricia Marie:	[phone]
Floriana Michalowska:	[phone]	Laure Bencheikh:	[phone]
Alix Sicaud:	[phone]
James Weston:	[phone]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DISFZGGFNMFGDZM